You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 7, 2024

CLINICAL TRIALS PROFILE FOR KETOTIFEN FUMARATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for KETOTIFEN FUMARATE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00426023 ↗ Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis Completed University of Genova Phase 3 2007-02-01 This interventional study aims to evaluate the efficacy of Cyclosporine eye drop treatment in preventing relapses of Vernal Keratoconjunctivitis (VKC) and in treating the acute phases of the disease.
NCT00426023 ↗ Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis Completed University of Padova Phase 3 2007-02-01 This interventional study aims to evaluate the efficacy of Cyclosporine eye drop treatment in preventing relapses of Vernal Keratoconjunctivitis (VKC) and in treating the acute phases of the disease.
NCT00426023 ↗ Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis Completed Campus Bio-Medico University Phase 3 2007-02-01 This interventional study aims to evaluate the efficacy of Cyclosporine eye drop treatment in preventing relapses of Vernal Keratoconjunctivitis (VKC) and in treating the acute phases of the disease.
NCT00445120 ↗ Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment Completed University of Genova Phase 2/Phase 3 2007-03-01 This interventional study aims to evaluate the efficacy of oral administration of Lactobacillus Rhamnosus GG in preventing relapses of ocular inflammation in Vernal Keratoconjunctivitis (VKC) patients.
NCT00445120 ↗ Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment Completed University of Padova Phase 2/Phase 3 2007-03-01 This interventional study aims to evaluate the efficacy of oral administration of Lactobacillus Rhamnosus GG in preventing relapses of ocular inflammation in Vernal Keratoconjunctivitis (VKC) patients.
NCT00445120 ↗ Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment Completed Campus Bio-Medico University Phase 2/Phase 3 2007-03-01 This interventional study aims to evaluate the efficacy of oral administration of Lactobacillus Rhamnosus GG in preventing relapses of ocular inflammation in Vernal Keratoconjunctivitis (VKC) patients.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for KETOTIFEN FUMARATE

Condition Name

Condition Name for KETOTIFEN FUMARATE
Intervention Trials
Allergic Conjunctivitis 2
Vernal Keratoconjunctivitis 2
Pleural Effusion 1
Rhinitis, Allergic, Perennial 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for KETOTIFEN FUMARATE
Intervention Trials
Conjunctivitis, Allergic 5
Conjunctivitis 3
Keratoconjunctivitis 2
Eczema 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for KETOTIFEN FUMARATE

Trials by Country

Trials by Country for KETOTIFEN FUMARATE
Location Trials
United States 6
Italy 2
Singapore 1
Japan 1
Argentina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for KETOTIFEN FUMARATE
Location Trials
Tennessee 3
Massachusetts 2
Arizona 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for KETOTIFEN FUMARATE

Clinical Trial Phase

Clinical Trial Phase for KETOTIFEN FUMARATE
Clinical Trial Phase Trials
Phase 4 3
Phase 3 8
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for KETOTIFEN FUMARATE
Clinical Trial Phase Trials
Completed 7
Not yet recruiting 3
Unknown status 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for KETOTIFEN FUMARATE

Sponsor Name

Sponsor Name for KETOTIFEN FUMARATE
Sponsor Trials
Bausch & Lomb Incorporated 3
University of Genova 2
University of Padova 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for KETOTIFEN FUMARATE
Sponsor Trials
Other 11
Industry 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.